| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT01758042 |
| P582 | end time | 2019-07-01 | |
| P921 | main subject | end stage renal failure | Q19001011 |
| P4135 | maximum age | 70 | |
| P1050 | medical condition | anemia | Q5445 |
| leukemia | Q29496 | ||
| chronic idiopathic myelofibrosis | Q3857106 | ||
| thalassemia | Q185137 | ||
| multiple myeloma | Q467635 | ||
| amyloidosis | Q816798 | ||
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 10 | |
| P6153 | research site | Massachusetts General Hospital | Q126412 |
| P1813 | short name | BMT | |
| P580 | start time | 2012-11-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Combined Haploidentical Reduced Intensity Bone Marrow and Kidney Transplantation for Patients With Chronic Kidney Disease and Advanced Hematological Disorders |
Search more.